Your browser doesn't support javascript.
loading
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
Baettig, Florence; Vlajnic, Tatjana; Vetter, Marcus; Glatz, Katharina; Hench, Jürgen; Frank, Stephan; Bihl, Michel; Lopez, Roberto; Dobbie, Michael; Heinzelmann-Schwarz, Viola; Montavon, Céline.
Affiliation
  • Baettig F; Department of Gynaecology and Obstetrics, Hôpital du Jura, Delémont, Switzerland.
  • Vlajnic T; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Vetter M; Gynaecological Cancer Centre, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Glatz K; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Hench J; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Frank S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Bihl M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Lopez R; Department of Gynaecology and Obstetrics, Hôpital du Jura, Delémont, Switzerland.
  • Dobbie M; Gynaecological Cancer Centre, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Heinzelmann-Schwarz V; Department of Oncology, Hôpital du Jura, Delémont, Switzerland.
  • Montavon C; Gynaecological Cancer Centre, University Hospital Basel and University of Basel, Basel, Switzerland.
J Immunother Cancer ; 7(1): 281, 2019 10 31.
Article in En | MEDLINE | ID: mdl-31672171

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vulvitis / Uterine Cervical Neoplasms / Drug Resistance, Neoplasm / Antineoplastic Agents, Immunological / Nivolumab Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: J Immunother Cancer Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vulvitis / Uterine Cervical Neoplasms / Drug Resistance, Neoplasm / Antineoplastic Agents, Immunological / Nivolumab Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: J Immunother Cancer Year: 2019 Document type: Article Affiliation country: Country of publication: